JACKSON SQUARE CAPITAL, LLC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.1%	0%	$491,052	63,773	0		$7.70	Q4 2025
30 Sep 2025	0.1%	0%	$470,007	63,773	0		$7.37	Q3 2025
30 Jun 2025	0.06%	0%	$255,092	63,773	0		$4.00	Q2 2025
31 Mar 2025	0.07%	0%	$202,798	63,773	0		$3.18	Q1 2025
31 Dec 2024	0.08%	0%	$341,186	63,773	0		$5.35	Q4 2024
30 Sep 2024	0.08%	0%	$336,721	63,773	0		$5.28	Q3 2024
30 Jun 2024	0.03%	0%	$116,067	63,773	0		$1.82	Q2 2024
31 Mar 2024	0.03%	0%	$113,516	63,773	0		$1.78	Q1 2024
31 Dec 2023	0.04%	0%	$112,240	63,773	0		$1.76	Q4 2023
30 Sep 2023	0.04%	0%	$93,109	63,773	0		$1.46	Q3 2023
30 Jun 2023	0.06%	0%	$146,040	63,773	0		$2.29	Q2 2023
31 Mar 2023	0.03%	0%	$58,033	63,773	0		$0.91	Q1 2023
31 Dec 2022	0.03%	0%	$54,207	63,773	0		$0.85	Q4 2022
30 Sep 2022	0.03%	0%	$52,000	63,773	0		$0.82	Q3 2022
30 Jun 2022	0.03%	0%	$63,000	63,773	0		$0.99	Q2 2022
31 Mar 2022	0.03%	+0.03%	$105,000	63,773	+63,773	NEW	$1.65	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.